CLNFF: RBC Capital Maintains Outperform Rating, May 2026

Calian Group Ltd. (CLNFF) keeps its Outperform rating from RBC Capital as the analyst firm raised its price target to C$90 from C$78 on May 15, 2026. The Canadian specialty business services company trades at $58.40, down 2.67% today but up significantly over longer periods. With a market cap of $666.6 million, CLNFF operates across defense, aerospace, health, and IT sectors. The analyst rating maintenance reflects confidence in the company’s strategic positioning despite near-term market volatility.

RBC Capital Maintains Outperform Rating on CLNFF

RBC Capital kept its Outperform rating on Calian Group while raising the price target significantly. The new target of C$90 represents a 15.4% increase from the previous C$78 level. This analyst rating maintained stance signals confidence in the company’s operational execution and growth trajectory.

The rating action reflects RBC’s view that CLNFF offers attractive upside potential. RBC Capital raised the price target to C$90 from C$78, demonstrating renewed conviction in the stock’s fundamentals. The analyst firm sees value in Calian’s diversified service portfolio across defense, aerospace, and IT sectors.

Financial Metrics and Valuation

CLNFF trades at a P/E ratio of 35.18 with earnings per share of $1.66. The company’s price-to-sales ratio stands at 1.10, indicating moderate valuation relative to revenue generation. Free cash flow per share reached $2.30, supporting the dividend yield of 1.39%.

Calian’s debt-to-equity ratio of 0.64 shows manageable leverage, while the current ratio of 1.51 indicates solid short-term liquidity. Return on equity of 10.35% reflects reasonable profitability. These metrics suggest the company maintains financial stability despite operating in competitive industrial sectors.

Stock Performance and Technical Outlook

CLNFF trades above its 50-day average of $53.65 and 200-day average of $44.12, showing positive momentum. The stock reached a 52-week high of $62.32 and low of $27.85, demonstrating significant volatility. Year-to-date performance shows a 40.52% gain, reflecting strong investor interest.

Meyka AI rates CLNFF with a grade of B+, suggesting a buy recommendation. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

Analyst Consensus and Growth Outlook

Four analysts currently rate CLNFF as Buy, with no Hold or Sell ratings in the consensus. This unanimous positive stance reflects broad market confidence in the company’s direction. Calian’s net income grew 83.87% year-over-year, while EPS surged 89.36%, demonstrating strong earnings expansion.

The company operates across four key segments: Advanced Technologies, Health, Learning, and IT. Revenue growth of 3.68% combined with margin expansion supports the analyst rating maintained by RBC Capital. Calian’s diversified revenue streams reduce sector-specific risk and provide multiple growth levers.

Final Thoughts

RBC Capital’s maintained Outperform rating and raised price target to C$90 underscore confidence in Calian Group’s strategic positioning. The analyst rating maintained reflects strong earnings growth, diversified operations, and solid financial metrics. With four Buy ratings and no Sell recommendations, CLNFF benefits from broad analyst support. The stock’s performance above key moving averages and Meyka’s B+ grade suggest positive momentum. Investors should monitor quarterly earnings and contract wins in defense and aerospace sectors for confirmation of the analyst rating thesis.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.